litlas
ログインアカウント作成

Philippe Rougier

1978–2024 年に発表

89
論文数
41,024
被引用数
84
h 指数
89
i10 指数

被引用数

Philippe Rougier の年別被引用数1981 年: 被引用 2 件1985 年: 被引用 3 件1986 年: 被引用 8 件1987 年: 被引用 5 件1988 年: 被引用 10 件1989 年: 被引用 2 件1990 年: 被引用 8 件1991 年: 被引用 10 件1992 年: 被引用 9 件1993 年: 被引用 11 件1994 年: 被引用 18 件1995 年: 被引用 19 件1996 年: 被引用 36 件1997 年: 被引用 33 件1998 年: 被引用 60 件1999 年: 被引用 87 件2000 年: 被引用 107 件2001 年: 被引用 109 件2002 年: 被引用 135 件2003 年: 被引用 134 件2004 年: 被引用 153 件2005 年: 被引用 179 件2006 年: 被引用 164 件2007 年: 被引用 188 件2008 年: 被引用 265 件2009 年: 被引用 366 件2010 年: 被引用 453 件2011 年: 被引用 408 件2012 年: 被引用 387 件2013 年: 被引用 355 件2014 年: 被引用 422 件2015 年: 被引用 364 件2016 年: 被引用 342 件2017 年: 被引用 352 件2018 年: 被引用 267 件2019 年: 被引用 983 件2020 年: 被引用 832 件2021 年: 被引用 748 件2022 年: 被引用 464 件2023 年: 被引用 374 件2024 年: 被引用 509 件2025 年: 被引用 247 件2026 年: 被引用 6 件1982〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,481 件、この内訳の 21.4%中国: 引用元論文 912 件、この内訳の 7.9%イタリア: 引用元論文 858 件、この内訳の 7.4%フランス: 引用元論文 852 件、この内訳の 7.3%イギリス: 引用元論文 746 件、この内訳の 6.4%ドイツ: 引用元論文 701 件、この内訳の 6%日本: 引用元論文 599 件、この内訳の 5.2%スペイン: 引用元論文 449 件、この内訳の 3.9%オランダ: 引用元論文 446 件、この内訳の 3.8%ベルギー: 引用元論文 344 件、この内訳の 3%カナダ: 引用元論文 301 件、この内訳の 2.6%韓国: 引用元論文 279 件、この内訳の 2.4%
0%21.4%その他 22.7%

機関

分野

  • Medicine79.9%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Immunology and Microbiology1.4%
  • Materials Science0.9%
  • Computer Science0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • その他2.3%

トピック

  • Colorectal Cancer Treatments and Studies12.2%
  • Hepatocellular Carcinoma Treatment and Prognosis6.8%
  • Gastric Cancer Management and Outcomes4.6%
  • Genetic factors in colorectal cancer3.5%
  • Cancer Genomics and Diagnostics3.5%
  • Colorectal Cancer Surgical Treatments3.4%
  • その他66%

共著者

全論文

検索で開く
  1. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

    著者: H. Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, G. Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae‐You Kim, David Cunningham, Philippe Rougier, Yoshito Komatsu, Jaffer A. Ajani, Michael Emig, Roberto Carlesi, David Ferry, Kumari Chandrawansa, Jonathan D. Schwartz, Atsushi Ohtsu - The Lancet Oncology 2014 被引用: 2,471

  2. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

    著者: Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, J. Załuski, Chung-Rong Chang Chien, Anatoly Makhson, Geert D’Haens, Tamás Pintér, Robert Lim, G. Bodoky, Jae Kyung Roh, Gunnar Folprecht, Paul Ruff, Christopher Stroh, Sabine Tejpar, Michael Schlichting, Johannes Nippgen, Philippe Rougier - New England Journal of Medicine 2009 被引用: 3,868

  3. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

    著者: Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, Graeme J. Poston, Peter M. Schlag, Philippe Rougier, Wolf O. Bechstein, John N Primrose, Euan Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W. Parks, Murielle Mauer, E. Tanis, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger - The Lancet Oncology 2013 被引用: 1,316

  4. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    著者: Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T. Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent‐Puig, Frédérique Penault–Llorca, Philippe Rougier, Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Federico Cappuzzo, Milo Frattini, Francesca Molinari, Piercarlo Saletti, Sara De Dosso, Miriam Martini, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi, Josep Tabernero, Teresa Macarulla, Frédéric FIORE, Alice Gangloff, Fortunato Ciardiello, Per Pfeiffer, Camilla Qvortrup, Tine Plato Hansen, Eric Van Cutsem, Hubert Piessevaux, Diether Lambrechts, Mauro Delorenzi, Sabine Tejpar - The Lancet Oncology 2010 被引用: 2,143

  5. Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer

    著者: Eric Van Cutsem, Heinz‐Josef Lenz, Claus-Henning Köhne, Volker Heinemann, Sabine Tejpar, I. Melezínek, Frank Beier, Christopher Stroh, Philippe Rougier, J. Han van Krieken, Fortunato Ciardiello - Journal of Clinical Oncology 2015 被引用: 800

  6. Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

    著者: Eric Van Cutsem, Claus-Henning Köhne, István Láng, Gunnar Folprecht, Marek P. Nowacki, Stefano Cascinu, I. Shchepotin, Joan Maurel, David Cunningham, Sabine Tejpar, Michael Schlichting, Angela Zubel, Ilhan Celik, Philippe Rougier, Fortunato Ciardiello - Journal of Clinical Oncology 2011 被引用: 1,887

  7. KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

    著者: Astrid Lièvre, Jean‐Baptiste Bachet, Delphine Le Corre, Valérie Boige, Bruno Landi, Jean‐François Emile, Jean‐François Côté, Gorana Tomasic, Christophe Penna, Michel Ducreux, Philippe Rougier, Frédérique Penault‐Llorca, Pierre Laurent‐Puig - Cancer Research 2006 被引用: 2,223

  8. Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

    著者: René Adam, Aimery de Gramont, Joan Figueras, Norihiro Kokudo, F Kunstlinger, Evelyne M. Loyer, Graeme J. Poston, Philippe Rougier, Laura Rubbia‐Brandt, Alberto Sobrero, Catherine Teh, Sabine Tejpar, Eric Van Cutsem, Jean‐Nicolas Vauthey, Lars Påhlman - Cancer Treatment Reviews 2015 被引用: 601

  9. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    著者: Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, Graeme J. Poston, Peter M. Schlag, Philippe Rougier, Wolf O. Bechstein, John N Primrose, Euan Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W. Parks, Laurence Collette, Michel Praet, Ullrich Bethe, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger - The Lancet 2008 被引用: 1,945

  10. The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus

    著者: René Adam, Aimery de Gramont, Joan Figueras, Ashley Guthrie, Norihiro Kokudo, F Kunstlinger, Evelyne M. Loyer, Graeme J. Poston, Philippe Rougier, Laura Rubbia‐Brandt, Alberto Sobrero, Josep Tabernero, Catherine Teh, Eric Van Cutsem, Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group - The Oncologist 2012 被引用: 594

  11. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

    著者: Julien Taı̈eb, Josep Tabernero, Enrico Mini, Fabien Subtil, Gunnar Folprecht, Jean-Luc Van Laethem, J. Thaler, John Bridgewater, Lone Nørgård Pétersen, Hélène Blons, Laurence Collette, Eric Van Cutsem, Philippe Rougier, Ramón Salazar, Laurent Bedenne, Jean‐François Emile, Pierre Laurent‐Puig, Côme Lepage - The Lancet Oncology 2014 被引用: 284

  12. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial

    著者: René Adam, Céline Piedvache, L. Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean‐Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valério Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Françis Lévi, M. Lewin, Maximiliano Gelli, Maximiliano Gelli, René Adam, René Adam, Céline Piedvache, Laurence Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean-Yves Mabrut, François Cauchy, Jean-Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valerio Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Francis Levi, Maïté Lewin, Maximiliano Gelli, Olivier Soubrane, Mickael Lesurtel, Jean Baptsite Bachet, Samuel Lesourd, Marine Jary, Mohamed Bouattour, Sara Lonardi, Mohamed Hebbar, Karim Boudjema, Denis Smith, Mircea Chirica, Thierry Lecomte, Chirstophe Borg, Rosine Guimbaud, Julien Taieb, Patrizia Burra, Philippe Rougier, Joan Figueras - The Lancet 2024 被引用: 159

  13. Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial

    著者: G. Portier, Dominique Elias, Olivier Bouché, Philippe Rougier, Jean-François Bosset, Jean Saric, Jacques Belghiti, Pascal Piedbois, Rosine Guimbaud, Bernard Nordlinger, R. Bugat, F Lazorthes, Laurent Bedenne - Journal of Clinical Oncology 2006 被引用: 578

  14. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials

    著者: Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier, Fortunato Ciardiello, S. Heeger, Michael Schlichting, Ilhan Celik, Claus‐Henning Köhne - European Journal of Cancer 2012 被引用: 593

  15. Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study

    著者: Rosine Guimbaud, Christophe Louvet, Pauline Ries, Marc Ychou, E. Maillard, Thierry André, Jean‐Marc Gornet, Thomas Aparicio, Suzanne Nguyen, A. Azzedine, Pierre-Luc Etienne, Éveline Boucher, Christine Rebischung, Pascal Hammel, Philippe Rougier, Laurent Bedenne, Olivier Bouché - Journal of Clinical Oncology 2014 被引用: 262

  16. KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

    著者: Astrid Lièvre, Jean‐Baptiste Bachet, Valérie Boige, Anne Cayre, Delphine Le Corre, Emmanuel Buc, Marc Ychou, Olivier Bouché, Bruno Landi, Christophe Louvet, Thierry André, Frédéric Bibeau, Marie-Danièle Diébold, Philippe Rougier, Michel Ducreux, Gorana Tomasic, Jean‐François Emile, Frédérique Penault–Llorca, Pierre Laurent‐Puig - Journal of Clinical Oncology 2008 被引用: 1,455

  17. Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

    著者: Eric Van Cutsem, Chris Twelves, Jim Cassidy, David Allman, Emilio Bajetta, Michael Boyer, R. Bugat, M Findlay, S. Frings, Michaela K. Jahn, Joe McKendrick, B Osterwalder, G. Pérez-Manga, Riccardo Rosso, Philippe Rougier, Wolff Schmiegel, Jean‐François Seitz, Paul Thompson, José María Viéitez, Christof Weitzel, Peter Harper - Journal of Clinical Oncology 2001 被引用: 1,036

  18. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

    著者: Eric Van Cutsem, Bernard Nordlinger, René Adam, Claus‐Henning Köhne, Carmelo Pozzo, Graeme J. Poston, Marc Ychou, Philippe Rougier - European Journal of Cancer 2006 被引用: 594

  19. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer.

    著者: E Lévy, Elliot Levy, P Piedbois, Marc Buyse, Jean‐Pierre Pignon, Philippe Rougier, Louise Ryan, Richard M. Hansen, Benny Zee, Brian Weinerman, J Pater, Cynthia G. Leichman, J Macdonald, Jacqueline Benedetti, J Lokich, J. Fryer, G Brufman, Rut Isacson, A. Laplanche, Emmanuel Quinaux - Journal of Clinical Oncology 1998 被引用: 491

  20. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

    著者: Thomas Walter, David Tougeron, Éric Baudin, Karine Le Malicot, Thierry Lecomte, David Malka, Olivia Hentic, Sylvain Manfrédi, Isabelle Bonnet, Rosine Guimbaud, Romain Coriat, Céline Lepère, Christophe Desauw, Anne Thirot‐Bidault, Laëtitia Dahan, Guillaume Roquin, Thomas Aparicio, Jean-Louis Legoux, Catherine Lombard‐Bohas, Jean‐Yves Scoazec, Côme Lepage, Guillaume Cadiot, Laetitia Stephanie, Ivan Borbath, Castex, Caroline Pétorin, Eric Terrebonne, Karine Bouhier‐Leporrier, Etienne Suc, Vincent Hautefeuille, Vincent Bourgeois, Laurent Cany, François Dewaele, Patricia Niccoli, Jean‐François Seitz, Cédric Lecaille, Christine Rebischung, Valérie Rossi, Mathieu Baconnier, Olivier Dubreuil, Marc Ferec, G. Deplanque, Guillaume Geslin, Isabelle Wanicki Caron, S. Lavau Denes, Laurent Bedenne, Catherine Poisson Ligeza, Eric Maringe, Anne-Laure Ran-Royo, J. Guigay, Philippe Rougier - European Journal of Cancer 2017 被引用: 112

  21. Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases

    著者: Mehdi Karoui, Christophe Penna, Mohamed Amin-Hashem, Emmanuel Mitry, Stéphane Benoist, Brigitte Franc, Philippe Rougier, Bernard Nordlinger - Annals of Surgery 2005 被引用: 720

  22. Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?

    著者: Stéphane Benoist, Antoine Brouquet, Christophe Penna, Catherine Julié, Mostafa El Hajjam, S Chagnon, Emmanuel Mitry, Philippe Rougier, Bernard Nordlinger - Journal of Clinical Oncology 2006 被引用: 602

  23. Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

    著者: Emmanuel Mitry, Anthony Fields, Harry Bleiberg, Roberto Labianca, G. Portier, Dongsheng Tu, Donato Nitti, Valter Torri, Dominique Elias, Chris J. O’Callaghan, Bernard Langer, Giancarlo Martignoni, Olivier Bouché, F Lazorthes, Eric Van Cutsem, Laurent Bedenne, Malcolm J. Moore, Philippe Rougier - Journal of Clinical Oncology 2008 被引用: 582

  24. Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

    著者: Philippe Rougier, Hanno Riess, Robert Manges, Petr Karásek, Yves Humblet, C. Barone, Armando Santoro, Sylvie Assadourian, Laurence Hatteville, Philip A. Philip - European Journal of Cancer 2013 被引用: 180